Pylera® (bismuth subcitrate potassium/metronidazole/tetracycline hydrochloride) in the eradication of Helicobacter pylori infection: a profile of its use in Europe
Crossref DOI link: https://doi.org/10.1007/s40267-017-0417-7
Published Online: 2017-06-09
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lyseng-Williamson, Katherine A. https://orcid.org/0000-0002-5104-1158
License valid from 2017-06-09